4.5 Review

Telomere biology in hematopoiesis and stem cell transplantation

期刊

BLOOD REVIEWS
卷 25, 期 6, 页码 261-269

出版社

CHURCHILL LIVINGSTONE
DOI: 10.1016/j.blre.2011.06.004

关键词

Telomeres; Bone marrow failure disorders; Hematopoietic stem cell transplant; Dyskeratosis congenita; Myelodysplastic syndrome; Pluripotent stem cells

资金

  1. Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health

向作者/读者索取更多资源

Telomeres are long (TTAGGG), nucleotide repeats and an associated protein complex located at the end of the chromosomes. They shorten with every cell division and, thus are markers for cellular aging, senescence, and replicative capacity. Telomere dysfunction is linked to several bone marrow disorders, including dyskeratosis congenita, aplastic anemia, myelodysplastic syndrome, and hematopoietic malignancies. Hematopoietic stem cell transplantation (HSCT) provides an opportunity in which to study telomere dynamics in a high cell proliferative environment. Rapid telomere shortening of donor cells occurs in the recipient shortly after HSCT; the degree of telomere attrition does not appear to differ by graft source. As expected, telomeres are longer in recipients of grafts with longer telomeres (e.g., cord blood). Telomere attrition may play a role in, or be a marker of, long term outcome after HSCT, but these data are limited. In this review, we discuss telomere biology in normal and abnormal hematopoiesis, including HSCT. Published by Elsevier Ltd.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据